Trends in Biopsy-Based Diagnosis of Kidney Disease: A Population Study

Abstract

Background:Kidney biopsy is considered the gold standard for diagnosis of renal disease. It is increasingly performed in cases of diagnostic uncertainty, including in patients with coexistent diabetes and hypertension, for which a presumptive clinical diagnosis can be made. Little is known about the incidence and distribution of biopsy-proven kidney diseases. Changes in the distribution of biopsy diagnoses over time may have significant implications for resource allocation and future research.Objective:We studied the relative frequency of kidney diseases in Southern Alberta over the past 30 years, to determine whether the population-standardized annual biopsy rate and incidence of selected diagnostic categories have changed. We hypothesized an increasing incidence of renal biopsies and a growing proportion of nonglomerular diseases (eg, tubulointerstitial disorders) likely due to evolving indications for biopsy. Given the rise in obesity, diabetes, and aging population with chronic kidney disease (CKD), we anticipated a rise in nephroangiosclerosis and diabetic nephropathy over time.Design:Retrospective population-based cohort study using the Biobank for the Molecular Classification of Kidney Disease (BMCKD).Setting:Southern Alberta, Canada.Patients:All patients who underwent renal biopsy between 1985 and 2015 in our database.Measurements:We used descriptive and quantitative analysis to characterize demographics and biopsy-based diagnoses.Methods:We conducted a retrospective population-based cohort study to analyze all consecutive patients who underwent at least one kidney biopsy over a 30-year period in Southern Alberta (1985-2015). We considered the first adequate biopsy. We described the annual standardized incidence of biopsy-proven kidney diseases over time and summarized associated patient characteristics. We assumed a Poisson distribution for biopsy counts and used provincial demographic information to standardize rates.Results:During the study period, 6434 people (58% male; mean age: 47.9 years) underwent a kidney biopsy. The population-standardized annual biopsy rate increased from 10.8 biopsies per 100 000 person-years in the first 5 years of the study (1985-1989) to 18.2 biopsies per 100 000 person-years in the last 5 years (2010-2014). The mean age at the time of biopsy increased from 42.5 years (1985-1989) to 51.4 years (2010-2014). Glomerular diseases remained the most prevalent histopathological group, with a growing representation of diabetic kidney disease from 3.69% to 16.18%, and a relative decrease in the proportion of other glomerular diseases from 72.32% to 62.92% of glomerular diagnoses. Tubulointerstitial diseases increased from 5.87% to 7.36% of total diagnoses.Limitations:Classification schemes have changed over time, so recently recognized conditions may have been misclassified in earlier data. There was a changing group of pathologists and nephrologists over this period. Variations in interpretation and application of biopsy indications by physician may influence recorded prevalence of...

Patterns in renal diseases diagnosed by kidney biopsy: A single-center experience

“…However, the incidence of IgA tended to increase significantly with the number of kidney biopsies for asymptomatic urinary abnormality (AUA) [14]. Moreover, easy access to procedures for kidney biopsies may influence the increased rates of biopsies and subsequently affect the epidemiologic characteristics of renal disease [15]. In a study of biopsy-proven renal disease in Korea, IgAN increased from 22.0% in the 1990s to 36.5% in the 2000s, with an increased indication of kidney biopsy for AUA.…”

Kr�ppel‑like factor�4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway

“…Diabetic kidney disease (DKD) is increasingly diagnosed and has become a leading cause of end-stage renal disease (ESRD) throughout the world during the past few decades (1,2). DKD is characterized by mesangial expansion, a thicker glomerular basement membrane, progressive glomerulosclerosis, and finally the development of progressive fibrosing kidney disease.…”

The Spectrum of Biopsy-Proven Glomerular Diseases in a Tertiary Hospital in Southern Brazil

“…A metanalysis of the epidemiology of glomerulonephritis in Africa showed a higher prevalence of minimal change disease (MCD) and FSGS 17 . In secondary glomerulopathies, studies have shown a higher prevalence of lupus nephritis (LN), diabetic kidney disease (DKD) and pauci-immune systemic vasculitis 8,11,18,19 , but with variations in its frequency over two decades 6,7,15 .…”

“…Temporal variation per period has been observed in the incidence rate of glomerular diseases, both in primary and secondary forms. Studies that evaluated two or more decades show an increasing trend in the prevalence of FSGS 7,16,20 , MCD 8,21 , DKD 7,15 , pauci-immune systemic vasculitis 6,7 and LN 6 , and also a temporal trend in the prevalence of NIgA 6,9,19,20 and membranous nephropathy (MN) 8,20 . There are records of differences related to ethnicity, with Asians having more cases of NIgA 8,18 , afrodescendants of FSGS and caucasians of MN 16 .…”